Scientific Opinion on the substantiation of a health claim related to Symbiosal® and lowering of blood pressure and reduced risk of hypertension pursuant to Article 14 of Regulation (EC) No 1924/2006

Scientific Opinion on the substantiation of a health claim related to Symbiosal® and lowering of blood pressure and reduced risk of hypertension pursuant to Article 14 of Regulation (EC) No 1924/2006

Abstract Following an application from Han‐Asiabiotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion...

Full description

Bibliographic Details
Main Author: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format: Article
Language:English
Published: Wiley 2015-07-01
Series:EFSA Journal
Subjects:
Symbiosal®
chitosan
sodium chloride
blood pressure
hypertension
health claims
Online Access:https://doi.org/10.2903/j.efsa.2015.4147

Internet

https://doi.org/10.2903/j.efsa.2015.4147

Similar Items